http://gulfstrategic.com/gc/wp-content/uploads/logo_final.jpg00PR PRhttp://gulfstrategic.com/gc/wp-content/uploads/logo_final.jpgPR PR2020-12-14 03:45:002020-12-14 05:07:15A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year – CNBC